全文获取类型
收费全文 | 2710篇 |
免费 | 166篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 107篇 |
妇产科学 | 53篇 |
基础医学 | 484篇 |
口腔科学 | 55篇 |
临床医学 | 177篇 |
内科学 | 450篇 |
皮肤病学 | 73篇 |
神经病学 | 226篇 |
特种医学 | 37篇 |
外科学 | 235篇 |
综合类 | 34篇 |
一般理论 | 2篇 |
预防医学 | 103篇 |
眼科学 | 86篇 |
药学 | 297篇 |
中国医学 | 20篇 |
肿瘤学 | 413篇 |
出版年
2024年 | 4篇 |
2023年 | 23篇 |
2022年 | 42篇 |
2021年 | 88篇 |
2020年 | 59篇 |
2019年 | 61篇 |
2018年 | 82篇 |
2017年 | 66篇 |
2016年 | 80篇 |
2015年 | 104篇 |
2014年 | 121篇 |
2013年 | 159篇 |
2012年 | 228篇 |
2011年 | 207篇 |
2010年 | 111篇 |
2009年 | 102篇 |
2008年 | 214篇 |
2007年 | 175篇 |
2006年 | 157篇 |
2005年 | 152篇 |
2004年 | 127篇 |
2003年 | 118篇 |
2002年 | 97篇 |
2001年 | 33篇 |
2000年 | 29篇 |
1999年 | 32篇 |
1998年 | 25篇 |
1997年 | 15篇 |
1996年 | 9篇 |
1995年 | 15篇 |
1994年 | 8篇 |
1993年 | 15篇 |
1992年 | 14篇 |
1991年 | 10篇 |
1990年 | 18篇 |
1989年 | 11篇 |
1988年 | 7篇 |
1987年 | 8篇 |
1986年 | 8篇 |
1985年 | 8篇 |
1983年 | 3篇 |
1980年 | 4篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1975年 | 3篇 |
1974年 | 4篇 |
1972年 | 3篇 |
1971年 | 5篇 |
1970年 | 2篇 |
1968年 | 2篇 |
排序方式: 共有2887条查询结果,搜索用时 15 毫秒
1.
Suraj Kumar Kulkarni Nagaraja Moorthy Rangaraj Ramalingam 《Echocardiography (Mount Kisco, N.Y.)》2019,36(3):598-601
Antiphospholipid antibody syndrome (APLS) is a rare disorder characterized by a hypercoagulable state. Manifestations include arterial or venous thrombosis, recurrent fetal wastage, coronary artery disease, valvular heart disease, dilated cardiomyopathy, pulmonary artery hypertension, and intracardiac thrombus. Most commonly mitral valve is affected followed by aortic and then tricuspid valve. In this report, a rare case of spontaneous aortic thrombosis with tricuspid stenosis uncomplicated by other valve lesions is presented with clinical and echocardiographic studies and computed tomographic images. 相似文献
2.
3.
M Vijaya Lakshmi MRCP G V Sridharan MRCP D Butterworth MRCP 《International journal of clinical practice》1993,47(3):164-165
Gallstones are common and their incidence increases with age.1 Fifty per cent of these stones are in the common bile duct (CBD) in the elderly.2 Most of them are silent but with time there is an increasing chance of developing symptoms which are more likely to be serious in the elderly.3 Failure to relieve mechanical obstruction of bile flow may lead to secondary biliary cirrhosis.4 It has been estimated that on average secondary biliary cirrhosis develops some seven years after the onset of obstruction from a stricture, four and half years after gallstone obstruction and 10 months after the onset of malignant stricture.5 The characteristic features are the pathological findings of portal-portal linkages, with a pattern of monolobular cirrhosis and the preservation of normal vascular relationships.6 Secondary biliary cirrhosis may lead to hepatic insufficiency and portal hypertension with the resultant complications, such as bleeding oesophageal varices, hypersplenism with pancytopenia, ascites and encephalopathy. We describe a patient in whom the diagnosis was not suspected until laparotomy and confirmed only at autopsy. 相似文献
4.
D K Srinivasa A Sahai S B Rotti M B Soudarssanane M Danabalan R N Sahoo K A Narayan G Ramalingam S Srinivasan S Mahadevan B V Bhat P Nalini 《Journal of epidemiology and community health》1997,51(4):443-448
STUDY OBJECTIVES: To assess the poliomyelitis trend, including study of the epidemiological features, and to correlate this with the immunisation coverage of infants. DESIGN: Three annual lameness surveys in children aged 0-60 months employing cluster sampling methods and a series of five cross sectional surveys of immunisation coverage in children aged 12-23 months of age were undertaken. SETTING: Pondicherry, India, 1988-92. SUBJECTS: More than 10,000 children in the age group of 0-60 months took part in the three annual lameness surveys and samples of 210 children aged 12-23 months were covered each year in immunisation coverage surveys. MEASUREMENTS AND MAIN RESULTS: Altogether 50 of 11,461, 24 of 10,093, and 17 of 11,218 children surveyed during 1989, 1990, and 1991 respectively had become lame as a result of poliomyelitis, giving prevalences of 4.4, 2.4, and 1.5 per 1000 children for the three surveys. The corrected prevalences of poliomyelitis were 5.9, 3.2, and 2.0 per 1000 children during 1989, 1990, and 1991 respectively. The proportion of cases aged up to 36 months fell from 48% in 1989 to 12.5% in 1990 and 6% in 1991. The age at onset was less than 1 year in most. The median age at onset was 10.7 months. About 54% of the affected children had received three doses of oral poliomyelitis vaccine (OPV) before the onset of paralysis. In 1988 immunisation coverage for the third dose of OPV was 91% and in 1992 it was 97.6%. The drop out rate for the first versus the third dose of OPV fell from 6.3 in 1988 to 1.9% in 1992. CONCLUSION: Three successive annual lameness surveys showed that poliomyelitis was declining between 1989 and 1991. Five immunisation coverage surveys conducted from 1988 to 1992 showed high initial coverage followed by an improvement in the form of almost universal coverage for OPV. 相似文献
5.
The expression of alpha melanocyte stimulating hormone (MSH) has been investigated in two variants of the B16 murine melanoma. The presence of MSH was demonstrated by immunohistochemical methods using anti-MSH antibodies. The low metastasis variant B16-F1, which grows as an encapsulated non-invasive tumour, showed no alpha-MSH immunoreactivity. In contrast, the high metastasis variant BL6 was found to be alpha-MSH positive and the immunoreactivity was found predominantly in the peripheral invading zones of the tumour. 相似文献
6.
7.
Uttam C. Garg Lakshmi Devi Herman Turndorf Lewis R. Goldfrank Mylarrao Bansinath 《Brain research》1992,592(1-2):208-212
In the brain, nitric oxide (NO) has been identified as a messenger molecule and a mediator of excitatory amino acid-induced neurotoxicity. In this study, the effects of NO on serum-induced mitogenesis and cell proliferation of the cerebellar glial cells were assessed. NO-generating agent, S-nitroso-N-acetylpenicillamine (SNAP) increased intracellular cyclic guanosine monophosphate (cGMP) levels. Furthermore, 2 chemically dissimilar NO-generating agents, SNAP and sodium nitroprusside (SNP) inhibited serum-induced thymidine incorporation and cell proliferation. The antimitogenic effect of NO was mimicked by 8-bromo-cGMP and blocked by hemoglobin, a known inhibitor of NO. The effect of NO was not cytotoxic, since the cells were not stained with Trypan blue and did not show increased release of lactate dehydrogenase in the culture supernatants. However, NO-treated cells showed decreased conversion of tetrazolium to blue formazan suggesting that NO inhibited mitochondrial activity in the glial cells. These results demonstrate that NO inhibits serum-induced mitogenesis and cell proliferation of cultured rat cerebellar glial cells. 相似文献
8.
Lakshmi Pendyala Patrick J. Creaven Robert Huben Dominique Tremblay Christine Bertagna 《Cancer chemotherapy and pharmacology》1988,22(1):69-76
Summary The pharmacokinetics of total radioactivity and unchanged drug were studied in patients receiving Anandron (Nilutamide, RU 23908) after a single dose of [14C] Anandron and after q12 h dosings of unlabelled drug for 2–7 weeks. The results indicate that the radioactivity in plasma consists of unchanged drug and metabolites. The plasma decay of Anandron after the absorption phase was biexponential in all patients, with the terminal phase half-life ranging from 23.3–87.2 h. The plasma decay of total radioactivity after the absorption phase was biexponential in 3/12 and monoexponential in 9/12 patients. The calculated terminal phase half-lives for total radioactivity after [14C] Anandron were 34.5–137.3 h. The AUC0– of the unchanged drug in plasma represented 23%–38% of the AUC0– of total radioactivity. Urinary radioactivity consisted primarily of metabolites, the majority of which were chloroform-nonextractable. Urinary excretion of radioactivity at 120 h ranged from 49%–78% of the administered dose; the unchanged Anandron (at 72 h) was 0.6%–1.3% of the dose. In three patients studied, the fecal excretion of Anandron was 1.4%–7.0%. Steady-state plasma levels (4.4–8.5 g/ml) were attained within approximately 2 weeks from the initiation of twice daily dosing of Anandron. When the plasma pharmacokinetics of radioactivity and unchanged drug after the first single dose were compared with that during steady state, AUC0–12 h of unchanged Anandron during steady state was significantly higher than the AUC0– after the first single dose, suggesting that the plasma clearance of Anandron is lowered upon chronic administration of the drug, assuming that the bioavailability is constant. 相似文献
9.
10.
Kannangai R Ramalingam S Vijayakumar TS Vincent AA Abraham OC Subramanian S Rupali P Mathai D Jesudason MV Sridharan G 《Indian journal of medical microbiology》2003,21(4):274-276
Currently, antiretroviral therapy has become more affordable even in developing countries and it is being used in India. Fifteen HIV-1 infected individuals, who were on highly active antiretroviral therapy (HAART), were followed up for an average period of one year. The plasma viral load and CD4+ T cell estimation done at mean intervals of 5 months and 11 months after initiation of therapy showed a good response to therapy in 14 (93%) individuals. 相似文献